FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称FELZARTAMAB
异名/同义词ANTI-CD38 MONOCLONAL ANTIBODY MOR03087
FELZARTAMAB
FELZARTAMAB [WHO-DD]
HUMAN RECOMBINANT IGG1 LAMBDA ANTI-CLUSTER OF DIFFERENTIATION 38 MONOCLONAL ANTIBODY EX HUMAN PER.C6 CELL LINE MOR202
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 ANTIGEN) (HUMAN MONOCLONAL MOR03087 .GAMMA.-1 CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MOR03087 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS CD38 (ADP-RIBOSYL CYCLASE 1, CYCLIC ADP-RIBOSE HYDROLASE 1, CADPR HYDROLASE 1, T10)), HUMANIZED MONOCLONAL ANTIBODY
MOR-03087
MOR-202
MOR03087
MOR202
TJ-202
TJ202
FELZARTAMAB [INN]
CAS登记号2197112-39-1
物质唯一标识(Unique Ingredient Identifier)3O9FA4XC02
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System